Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Absence of NR2E1 mutations in patients with aniridia.
[aniridia]
Nuclear
receptor
2
E
1
(
NR
2
E
1
)
is
a
transcription
factor
with
many
roles
during
eye
development
and
thus
may
be
responsible
for
the
occurrence
of
certain
congenital
eye
disorders
in
humans
.
To
test
this
hypothesis
,
we
screened
NR
2
E
1
for
candidate
mutations
in
patients
with
aniridia
and
other
congenital
ocular
malformations
(
anterior
segment
dysgenesis
,
congenital
optic
nerve
malformation
,
and
microphthalmia
)
.
The
NR
2
E
1
coding
region
,
5
'
and
3
'
untranslated
regions
(
UTRs
)
,
exon
flanking
regions
including
consensus
splice
sites
,
and
six
evolutionarily
conserved
non-coding
candidate
regulatory
regions
were
analyzed
by
sequencing
58
probands
with
aniridia
of
whom
42
were
negative
for
PAX
6
mutations
.
Nineteen
probands
with
anterior
segment
dysgenesis
,
one
proband
with
optic
nerve
malformation
,
and
two
probands
with
microphthalmia
were
also
sequenced
.
The
control
population
comprised
376
healthy
individuals
.
All
sequences
were
analyzed
against
the
GenBank
sequence
AL
078596
.
8
for
NR
2
E
1
.
In
addition
,
the
coding
region
and
flanking
intronic
sequences
of
FOXE
3
,
FOXC
1
,
PITX
2
,
CYP
1
B
1
,
PAX
6
,
and
B
3
GALTL
were
sequenced
in
one
patient
and
his
relatives
.
Sequencing
analysis
showed
17
NR
2
E
1
variants
including
two
novel
rare
non-coding
variants
(
g
.
-
1507
G
>
A
,
g
.
14258
C
>
T
)
,
and
one
novel
rare
coding
variant
(
p
.
Arg
274
Gly
)
.
The
latter
was
present
in
a
male
diagnosed
with
Peters
'
anomaly
who
subsequently
was
found
to
have
a
known
causative
mutation
for
Peters
'
plus
syndrome
in
B
3
GALTL
(
c
.
660
+
1
G
>
A
)
.
In
addition
,
the
NR
2
E
1
novel
rare
variant
Arg
274
G
ly
was
present
in
the
unaffected
mother
of
the
patient
but
absent
in
746
control
chromosomes
.
We
eliminated
a
major
role
for
NR
2
E
1
regulatory
and
coding
mutations
in
aniridia
and
found
a
novel
rare
coding
variant
in
NR
2
E
1
.
In
addition
,
we
found
no
coding
region
variation
in
the
control
population
for
NR
2
E
1
,
which
further
supports
its
previously
reported
high
level
of
conservation
and
low
genetic
diversity
.
Future
NR
2
E
1
studies
in
ocular
disease
groups
such
as
those
involving
retinal
and
optic
nerve
abnormalities
should
be
undertaken
to
determine
whether
NR
2
E
1
plays
a
role
in
these
conditions
.
Diseases
Validation
Diseases presenting
"rare non-coding variants"
symptom
aniridia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom